Actively Recruiting
Attribution of Toxicities Due to Radiotherapy and Immuno-Biological Therapies
Led by Centre hospitalier de l'Université de Montréal (CHUM) · Updated on 2024-06-28
3600
Participants Needed
1
Research Sites
315 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Every year, new molecular agents enter the market with more and more patients receiving these treatments, especially in the metastatic setting. These molecular agents could correspond to immunotherapy and modulators of signaling pathways. More than 50% of cancer patients will receive radiation therapy during the course of their illness, including radiotherapy aimed a palliating symptoms secondary to metastatic diseases. Therefore, there will be an increasing number of patients who will be receiving radiotherapy while they are still receiving molecular agents. A better understanding of the interaction of these two treatment modalities is needed.
CONDITIONS
Official Title
Attribution of Toxicities Due to Radiotherapy and Immuno-Biological Therapies
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Consent to be part of the AtTRIBut registry
- Prior histological diagnosis of primary cancer
- Radiological or pathological evidence of metastasis if metastatic disease is present
- Age over 18 years
- Currently receiving a molecular therapy
- Indicated to receive radiotherapy
- Radiation therapy may be administered using 3D conventional, IMRT, or SBRT techniques
You will not qualify if you...
- Refusal or inability to receive radiotherapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre Hospitalier de l'Université de Montréal
Montreal, Quebec, Canada, H2X 0A9
Actively Recruiting
Research Team
M
Mom Phat, RN
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here